Cell Impact reports second quarter results for 2021: Strong growth

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the first quarter.

  • Total revenues for the second quarter amounted to SEK 17.8 million (4.8), which is growth of 270% for the quarter.
  • Operating result was SEK -23.5 million (-13.3).
  • The Group's result after financial items was SEK -23.8 million (-13.8).
  • Earnings per share attributable to the shareholders of the Parent Company totaled SEK -0.41 (-0.30).
  • Equity was SEK 163.9 million (58.4) or SEK 2.79 per share (1.13) as at the balance sheet date.
  • Debt/equity ratio was 75% (73%) on the balance sheet date.
  • Cash flows from operating activities amounted to SEK -26.1 million (-8.6) during the quarter.
  • On the balance sheet date, the Group's cash and cash equivalents totaled SEK 93.8 million (34.4).

Significant events in the period

May 5, 2021 | Cell Impact strengthens management with new COO.

For more information, please contact:

Stefan Axellie, CFO, +46 70-343 46 55 or [email protected].

About Cell Impact

Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell manufacturers. The company has developed and patented a unique method for high-velocity forming, Cell Impact Forming, which makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional forming methods.

The Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden AB is the company's Certified Advisor (CA). Contact info: +46 8-528 00 399 or [email protected].

This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.

Cell Impact delårsrapport för tredje kvartalet: Fortsatt stark tillväxt

Cell Impact AB (Nasdaq First North GM: CI B) lämnar följande finansiella sammanfattning för tredje kvartalet.


Cell Impact reports third quarter results: Continued strong growth

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the third quarter.




Cell Impact förstärker ledningen med ny HR-chef

Cell Impact AB (Nasdaq First North GM: CI B) meddelar att Karina Sick Larsson har utsetts till Chief Human Resources Officer (CHRO) med tillträdesdag 16 september 2021. Karina kommer ansvara för bolagets HR-funktion med fokus kompetensutveckling.


Cell Impact strengthens management with new CHRO

Cell Impact AB (Nasdaq First North GM: Cell Impact AB (Nasdaq First North GM: CI B) is pleased to announce that Karina Sick Larsson has been appointed as Chief Human Resources Officer (CHRO) and will start her position on September 16, 2021. Karina will be responsible for the company's human resources function with a focus on organizational development.


Cell Impact delårsrapport för andra kvartalet 2021: Stark tillväxt

Cell Impact AB (Nasdaq First North GM: CI B) lämnar följande finansiella sammanfattning för första kvartalet.


Cell Impact reports second quarter results for 2021: Strong growth

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the first quarter.


Kommuniké från extra bolagstämma i Cell Impact AB

Extra bolagstämma i Cell Impact AB (Nasdaq First North GM: CI B) hölls den 9 augusti 2021.


Extraordinary general meeting of Cell Impact AB

An extraordinary general meeting of Cell Impact AB (Nasdaq First North GM: CI B) was held on August 9, 2021.


Kallelse till extra bolagsstämma i Cell Impact

Aktieägarna i Cell Impact AB (Nasdaq First North GM: CI B), org.nr 556576-6655, kallas härmed till extra bolagsstämma måndagen den 9 augusti 2021.


Notice of extraordinary general meeting of Cell Impact

The shareholders of Cell Impact AB (Nasdaq First North GM: CI B), reg. no. 556576-6655, are hereby invited to participate in an extraordinary general meeting on Monday 9 August 2021.


Cell Impact Japan Inc får order på 5,3 miljoner SEK

Ordern omfattar utveckling av verktyg och prototyptillverkning av flödesplattor. Leverans beräknas till tredje kvartalet 2021. Ordern är en fortsättning på tidigare initierade aktiviteter inom ramen för partnerskapet med NKC Japan.


Cell Impact Japan Inc. receives order worth SEK 5.3 million

The order is for development of flow plate tooling and flow plate prototype production and will be delivered duringthe third quarter of 2021. This order is a continuation of earlier established activities in Japan as part of the cooperation with NKC Japan.


Cell Impact förstärker ledningen med ny COO

Cell Impact AB (Nasdaq First North GM: CI B) meddelar att Daniel Vallin har utsetts till ny operativ chef (COO)med tillträdesdag 16 augusti 2021. Han efterträder Tord Lätt som tar över rollen som projektchef (CPO) med ansvar för bolagets program för automationsutveckling.


Cell Impact strengthens management with new COO

Cell Impact AB (Nasdaq First North GM: CI B) is pleased to announce that Daniel Vallin has been appointed new Chief Operating Officer (COO) and will start his new position on August 16, 2021. He will succeed Tord Lätt, who will take over the role of Chief Project Manager (CPO) with responsibility for Cell Impact's automation development program.


Cell Impact delårsrapport för första kvartalet 2021

Cell Impact AB (Nasdaq First North GM: CI B) lämnar följande finansiella sammanfattning för första kvartalet.


Cell Impact reports first quarter results for 2021

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the first quarter.


Kommuniké från årsstämma 2021 i Cell Impact

Cell Impact AB (Nasdaq First North GM: CI B) höll under torsdagen den 22 april 2021 årsstämma för verksamhetsåret 2020.


Annual general meeting 2021 of Cell Impact

Cell Impact AB's (Nasdaq First North GM: CI B) annual general meeting for the financial year 2020 was held on 22 April, 2021.


Följ oss

Om beQuoted

beQuoted publicerar nyheter, analyser och pressmeddelanden för investerare och journalister. Viktiga företagshändelser bevakas av vår egen nyhetsredaktion och vidaredistribueras i ledande finansiella medier.

Vi uppdaterar även nyhetsrum, Investor Relations och IR-webbplatser för företag som vill utveckla sina relationer med finansmarknaden.

Kontakta oss

beQuoted AB
Nybrogatan 34
Box 5216
102 45 Stockholm

08-692 21 90

Om beQuoted